Three Seasons Wealth LLC Purchases 6,445 Shares of HealthEquity, Inc. $HQY

Three Seasons Wealth LLC increased its position in HealthEquity, Inc. (NASDAQ:HQY) by 116.7% in the first quarter, HoldingsChannel reports. The firm owned 11,966 shares of the company’s stock after purchasing an additional 6,445 shares during the quarter. Three Seasons Wealth LLC’s holdings in HealthEquity were worth $1,000,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Capricorn Fund Managers Ltd purchased a new position in HealthEquity during the 4th quarter valued at about $6,926,000. Congress Asset Management Co. increased its stake in shares of HealthEquity by 36.3% during the fourth quarter. Congress Asset Management Co. now owns 101,816 shares of the company’s stock valued at $9,327,000 after purchasing an additional 27,102 shares in the last quarter. Oxbow Advisors LLC bought a new position in shares of HealthEquity during the first quarter valued at approximately $3,147,000. Westfield Capital Management Co. LP lifted its holdings in shares of HealthEquity by 13.7% during the fourth quarter. Westfield Capital Management Co. LP now owns 1,952,452 shares of the company’s stock valued at $178,864,000 after purchasing an additional 235,794 shares during the last quarter. Finally, Sumitomo Mitsui DS Asset Management Company Ltd purchased a new position in shares of HealthEquity during the fourth quarter valued at approximately $4,381,000. 99.55% of the stock is currently owned by institutional investors.

Insider Activity at HealthEquity

In other HealthEquity news, EVP Michael Henry Fiore sold 3,142 shares of HealthEquity stock in a transaction on Friday, May 29th. The stock was sold at an average price of $95.00, for a total value of $298,490.00. Following the completion of the sale, the executive vice president owned 59,113 shares of the company’s stock, valued at approximately $5,615,735. This trade represents a 5.05% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Delano Ladd sold 7,500 shares of the business’s stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $675,000.00. Following the completion of the transaction, the executive vice president owned 91,141 shares of the company’s stock, valued at $8,202,690. This represents a 7.60% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 17,905 shares of company stock valued at $1,651,280. 1.60% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on HQY. Wells Fargo & Company set a $111.00 price target on HealthEquity in a research report on Monday, June 1st. Wall Street Zen lowered HealthEquity from a “buy” rating to a “hold” rating in a research report on Saturday, July 4th. Barrington Research reiterated an “outperform” rating and set a $110.00 price objective on shares of HealthEquity in a research note on Friday, May 22nd. Royal Bank Of Canada boosted their target price on HealthEquity from $100.00 to $108.00 and gave the stock an “outperform” rating in a report on Wednesday, June 3rd. Finally, Citigroup reissued a “market outperform” rating on shares of HealthEquity in a research note on Monday, June 1st. Eleven analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $110.57.

HealthEquity Stock Up 0.6%

Shares of HealthEquity stock opened at $95.07 on Thursday. The company has a debt-to-equity ratio of 0.46, a quick ratio of 3.44 and a current ratio of 3.44. The stock has a market capitalization of $7.95 billion, a PE ratio of 35.61, a price-to-earnings-growth ratio of 1.59 and a beta of 0.21. HealthEquity, Inc. has a 52-week low of $72.76 and a 52-week high of $105.96. The company has a 50-day simple moving average of $88.21 and a two-hundred day simple moving average of $84.66.

HealthEquity (NASDAQ:HQY) last issued its earnings results on Thursday, May 28th. The company reported $1.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.11 by $0.13. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. The firm had revenue of $354.64 million for the quarter, compared to the consensus estimate of $352.02 million. The business’s quarterly revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. On average, analysts anticipate that HealthEquity, Inc. will post 3.92 EPS for the current fiscal year.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.